AI assistant
Sending…
Nautilus Biotechnology, Inc. — Director's Dealing 2021
Dec 21, 2021
34183_dirs_2021-12-21_8a645538-3198-4e91-ba44-150141d1b3b5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Nautilus Biotechnology, Inc. (NAUT)
CIK: 0001808805
Period of Report: 2021-12-21
Reporting Person: Mallick Parag (Director, Chief Scientist, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-21 | Common Stock | G | 210000 | — | Disposed | 20479892 | Direct |